Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma

Completed · Not applicable

Conditions studied: Malignant Melanoma

In brief

This is a randomized non-blinded pilot study for patients with melanoma staging cT2N0M0 who are candidates for surgical resection. The primary objective is to determine the feasibility of randomizing participants with cT2N0M0 malignant melanoma to surgical treatment with 1cm versus 2cm margins. Study will try to determine overall survival for cT2N0M0 malignant melanoma after surgical treatment with 1cm versus 2cm margins.

Key facts

Study ID

NCT03034395

Run by

University of Kansas Medical Center

People needed

15

Starts

2017-01-30

Expected to finish

2020-11-04

Last updated by the study team

2021-05-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy proven T2 malignant melanoma.
• Eastern Cooperative Oncology Group (ECOG) score of 0-2.

You may not qualify if…

• Visible additional disease that suggests a greater than T2 malignant melanoma
• Unable to tolerate general anesthesia
• Evidence of distant metastatic disease
• Melanoma located on face or digits

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.